Providers' HIV prevention discussions with HIV-seropositive injection drug users

James D. Wilkinson, Wei Zhao, Scott Santibanez, Julia Arnsten, Amy Knowlton, Cynthia A. Gómez, Lisa R. Metsch, Carl Latkin, Amy Knowlton, Karin Tobin, Lisa Metsch, Eduardo Valverde, James Wilkinson, Martina DeVarona, Mary Latka, Dave Vlahov, Phillip Coffin, Marc Gourevitch, Julia Arnsten, Robert GernCynthia Gomez, Kelly Knight, Carol Dawson Rose, Starley Shade, Sonja Mackenzie, David Purcell, Yuko Mizuno, Scott Santibanez, Richard Garfein, Ann O'Leary, Lois Eldred, Kathleen Handley

Research output: Contribution to journalArticlepeer-review


Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.

Original languageEnglish (US)
Pages (from-to)699-705
Number of pages7
JournalAIDS and Behavior
Issue number6
StatePublished - Nov 2006


  • Acquired immunodeficiency syndrome
  • Human immunodeficiency virus
  • Prevention and control
  • Primary health care
  • Substance abuse, intravenous

ASJC Scopus subject areas

  • Social Psychology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Providers' HIV prevention discussions with HIV-seropositive injection drug users'. Together they form a unique fingerprint.

Cite this